News
A microfluidic biochip for blood cell counts
Researchers say they have created a biosensor capable of counting blood cells electrically using only a drop of blood. The microfluidic device...
News
Myeloma drug could treat sickle cell disease, team says
and a normal one Image by Betty Pace Preclinical research suggests a drug used to treat multiple myeloma (MM) might also prove effective in the...
News
Antiplatelet agent shows promise in phase 1 trial
Image by Andre E.X.
News
A potential target for IDH1-mutant cancers
acute myeloid leukemia Researchers say they have identified a potential therapeutic target for IDH1-mutant malignancies. Preclinical experiments...
News
Fear really does curdle blood, study suggests
Photo by Graham Colm Horror movies may actually be “blood-curdling,” according to a study published in The BMJ. The research showed that...
News
Preoperative VTE prophylaxis is safe for cancer patients, team says
Preoperative anticoagulant therapy is safe and effective for cancer patients, a single-center study suggests. Among patients undergoing major...
News
Study reveals decrease in NIH-funded trials
Photo by Esther Dyson A new study suggests that, in recent years, there has been a decrease in clinical trials funded by the National Institutes...
News
Group finds inconsistencies in genome sequencing procedures
Photo courtesy of NIGMS Researchers say they have identified substantial differences in the procedures and quality of cancer genome sequencing...
News
Genes can stop onset of AML, study suggests
Image by Lance Liotta Two genes can stop the development of acute myeloid leukemia (AML), according to research published in the Journal of...
News
Approach can help reduce VTE after surgery
Photo by Piotr Bodzek New research suggests that individualized feedback is more effective than group instructions for helping general surgery...
News
FDA approves rapid-infusion bendamustine
Photo by Bill Branson The US Food and Drug Administration (FDA) has approved the use of Bendeka, a liquid, low-volume (50 mL), 10-minute infusion...
News
Rivaroxaban performs as expected in clinical practice
ORLANDO, FL—“Real-world” data appear to confirm phase 3 results with rivaroxaban in patients who have deep vein thrombosis (DVT), with or without...
News
2nd-gen BTK inhibitor may be safer, team says
ORLANDO, FL—The second-generation BTK inhibitor acalabrutinib (ACP-196) can elicit durable partial responses in patients with chronic lymphocytic...
News
FDA grants KTE-C19 breakthrough designation
The US Food and Drug Administration (FDA) has granted breakthrough designation for the chimeric antigen receptor (CAR) T-cell therapy KTE-C19 as a...
News
Antiplatelet agent proves ineffective in SCD
Photo courtesy of St.